Bringwell Pharma Private Limited - Company Profile

It is a pharma private limited company based in Ghaziabad, Uttar Pradesh, India, established in 2020.
2020 Ghaziabad, Uttar Pradesh, India Active
Last Updated:
Access Report
About Bringwell Pharma Private Limited

Bringwell Pharma Private Limited, a active private limited company, was established on 12 November 2020 in Ghaziabad, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230UP2020PTC137934. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Brij Raj Singh (Director), Sunil Kumar Mangla (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at D01/001.1B, Dlf Dilsad Plaza, Dilshad Extension, Bhopura, Sahibabad,, Ghaziabad, Uttar Pradesh, 201005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230UP2020PTC137934

  • Registration Number

    137934

  • Incorporation Date

    12 November 2020

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 5 Year, 3 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** 1525.73%
  • Profit Growth **** -34.24%
  • Ebitda **** -55.31%
  • Net Worth -31.60%
  • Total Assets -31.60%
Company report

Bringwell Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bringwell Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Bringwell Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Brij Raj Singh Director 12 Nov 2020 Current
Sunil Kumar Mangla Director 12 Nov 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bringwell Pharma.

Bringwell Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1525.73% increase. The company also saw a substantial fall in profitability, with a 34.24% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.6%.

Bringwell Pharma revenue growth over time
Bringwell Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 1525.73%
*******
*******
*******
*******
Revenue from Operations
*******
 1525.73%
*******
*******
*******
*******
Total Assets
*******
 -31.60%
*******
*******
*******
*******
Profit or Loss
*******
 -34.24%
*******
*******
*******
*******
Net Worth
*******
 -31.60%
*******
*******
*******
*******
EBITDA
*******
 -55.31%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bringwell Pharma?

In 2022, Bringwell Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bringwell Pharma?

Bringwell Pharma has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bringwell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bringwell Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bringwell Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Bringwell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Bringwell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    The activity Brij Raj Singh was appointed as a Director was appointed as a Director on 12 Nov 2020 & has been associated with this company since 5 years 3 months . was completed.

  • Director Appointment

    The activity Sunil Kumar Mangla was appointed as a Director was appointed as a Director on 12 Nov 2020 & has been associated with this company since 5 years 3 months . was completed.

  • Company Incorporation

    The activity Bringwell Pharma Private Limited was registered on 12 Nov 2020 with Roc Kanpur & aged 5 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bringwell Pharma Private Limited?

The CIN of Bringwell Pharma Private Limited is U24230UP2020PTC137934.

Where is Bringwell Pharma Private Limited headquartered?

Bringwell Pharma Private Limited is headquartered at D01/001.1B, Dlf Dilsad Plaza, Dilshad Extension, Bhopura, Sahibabad,, Ghaziabad, Uttar Pradesh, 201005.

When was Bringwell Pharma Private Limited incorporated?

Bringwell Pharma Private Limited was incorporated on 12 November 2020.

Who are the current directors of Bringwell Pharma Private Limited?

The current directors of Bringwell Pharma Private Limited are

What is the primary industry of Bringwell Pharma Private Limited?

The primary industry of Bringwell Pharma Private Limited is Trade.

Is Bringwell Pharma Private Limited a listed company?

Bringwell Pharma Private Limited is unlisted.

What is the capital structure of Bringwell Pharma Private Limited?

The authorized capital of Bringwell Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available